Skip to Main Content

Author Details

Yann Le Cam
2012
23
12
PMIDPaper TitleJournal TitlePublished Year
37308991Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years' multi-stakeholder dialogue on improving access in Europe via MoCA.Orphanet J Rare Dis2023
35645285Towards Achieving Equity and Innovation in Newborn Screening across Europe.Int J Neonatal Screen2022
33262444Reply to E. Vicente et al.Eur J Hum Genet2021
33884523Our greatest untapped resource: our patients.J Community Genet2021
34975469Orphan Medicine Incentives: How to Address the Unmet Needs of Rare Disease Patients by Optimizing the European Orphan Medicinal Product Landscape Guiding Principles and Policy Proposals by the European Expert Group for Orphan Drug Incentives (OD Expert Group).Front Pharmacol2021
31527858Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.Eur J Hum Genet2020
29901216Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?Clin Pharmacol Ther2019
28796411Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.Clin Transl Sci2018
29911566[French model for Europe and Europe as a model for France in the field of rare diseases].Med Sci (Paris)2018
29977052The evolution of adaptiveness: balancing speed and evidence.Nat Rev Drug Discov2018
27782107'IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases.Eur J Hum Genet2017
28283046Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL).Orphanet J Rare Dis2017
29158551The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact.Eur J Hum Genet2017
29214566Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.Adv Exp Med Biol2017
26929314A model for active and healthy ageing with a rare genetic disease: cystic fibrosis.Eur Respir J2016
26911987The context for the thematic grouping of rare diseases to facilitate the establishment of European Reference Networks.Orphanet J Rare Dis2016
25537360The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases.Eur J Hum Genet2015
25669457From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients.Clin Pharmacol Ther2015
24513034Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectives.Orphanet J Rare Dis2014
24922305European Reference Networks for Rare Diseases: the vision of patients.Blood Transfus2014
24503588EUROPLAN: a project to support the development of national plans on rare diseases in Europe.Public Health Genomics2013
22258596Leap year: Rare day to highlight rare diseases.Nature2012
23293582Involvement of patient organisations in research and development of orphan drugs for rare diseases in europe.Mol Syndromol2012
  • 1 - 23 of 23

Recommended Authors

Institute of Genetic Medicine, Newcastle University International Centre for Life
Career Start Year 2016
Number of shared co-authors 15
Wilhelm Foundation
Career Start Year 2015
Number of shared co-authors 13
Hopp Children's Cancer Center (KiTZ)
Career Start Year 2015
Number of shared co-authors 0
Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham
Career Start Year 2014
Number of shared co-authors 10
National Heart and Lung Institute
Career Start Year 2013
Number of shared co-authors 0
Center for Outcomes Research and Evaluation, Yale-New Haven Hospital
Career Start Year 2012
Number of shared co-authors 0
Stanford University
Career Start Year 2010
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 9
Harvard Medical School
Career Start Year 2007
Number of shared co-authors 9
Institute for Biomedicine (Affiliated Institute of the University of Lubeck)
Career Start Year 2007
Number of shared co-authors 13
Vanderbilt University School of Medicine
Career Start Year 2005
Number of shared co-authors 0
University of Cape Town
Career Start Year 2002
Number of shared co-authors 1
12328Vanderbilt University Medical Center
Career Start Year 2001
Number of shared co-authors 0
Medical Ethics and Health Policy, University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 1
Wyss Institute for Biologically Inspired Engineering, Harvard University
Career Start Year 1999
Number of shared co-authors 2
Canadian Arthritis Patient Alliance and Five02 Labs Inc.
Career Start Year 1999
Number of shared co-authors 0
Biomedical Ethics Research Program & Center for Regenerative Medicine, Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
university of massachusetts amherst Chan Medical School
Career Start Year 1998
Number of shared co-authors 1
Lovisenberg Diaconal Hospital
Career Start Year 1998
Number of shared co-authors 0
Center for Human Genetics and Genomics, NYU Grossman School of Medicine
Career Start Year 1997
Number of shared co-authors 1
Congenica Ltd
Career Start Year 1995
Number of shared co-authors 9
INSERM UMR 3, Universite Paris Cite, Imagine Institute
Career Start Year 1994
Number of shared co-authors 0
Stanford University
Career Start Year 1994
Number of shared co-authors 1
Institute of AI and Informatics in Medicine, Technical University of Munich
Career Start Year 1992
Number of shared co-authors 0
National Institutes of Health (NIH)
Career Start Year 1992
Number of shared co-authors 12
University Medical Center Utrecht
Career Start Year 1991
Number of shared co-authors 2
Institute of Rare Diseases Research, Instituto de Salud Carlos III
Career Start Year 1986
Number of shared co-authors 18
Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University
Career Start Year 1982
Number of shared co-authors 2
Stellenbosch Institute of Advanced Study, University of Toronto
Career Start Year 1976
Number of shared co-authors 0

Collaborators

Children's Hospital of Eastern Ontario Research Institute
Co-authored papers 5
Novartis Gene Therapies
Co-authored papers 4
The University of Notre Dame Australia
Co-authored papers 4
McGill University. Montreal
Co-authored papers 4
St. George's University Medical School
Co-authored papers 4
INSERM
Co-authored papers 4
Children's Hospital of Eastern Ontario
Co-authored papers 4
King Edward Memorial Hospital
Co-authored papers 4
Institute of Genetic Medicine, International Centre for Life
Co-authored papers 3
INSERM
Co-authored papers 3
Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III (ISCIII)
Co-authored papers 3
John Walton Muscular Dystrophy Research Centre, Newcastle University
Co-authored papers 2
The Janssen Pharmaceutical Companies of Johnson & Johnson
Co-authored papers 2
National Center for Rare Diseases, Istituto Superiore di Sanita
Co-authored papers 2
King Edward Memorial Hospital for Women Perth
Co-authored papers 1
Massachusetts Institute of Technology
Co-authored papers 1
Paris Brain Institute-ICM, Inserm U 7, CNRS UMR 7225, Sorbonne Universite
Co-authored papers 1
Keio University School of Medicine
Co-authored papers 1
University of Western Australia
Co-authored papers 1
Institut National de la Sante et de la Recherche Medicale
Co-authored papers 1
Australia UNSW RNA Institute
Co-authored papers 1
Co-authored papers 1
Children's Hospital of Eastern Ontario Research Institute
Co-authored papers 1
King Edward Memorial Hospital for Women
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Siena
Co-authored papers 1
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 1
King Edward Memorial Hospital
Co-authored papers 1
University of Western Australia
Co-authored papers 1